CVS, Caremark sweeten offer to $26.3B

CVS Corp. (NYSE: CVS) and Caremark Rx Inc. (NYSE: CMX) today announced “enhancements” to their planned merger in response to rival Express Scripts’ (Nasdaq: ESRX) sweetening last night of its $26.1 billion hostile takeover offer. In what CVS called its “best and final merger proposal,” it and Caremark agreed to increase their special cash dividend…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -